Search Contract Opportunities

Buspirone RFP   3

ID: 36E79725R0024 • Type: Presolicitation • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this solicitation list any subcontracting requirements?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Page 4 of 4 Page 4 of 4 PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0024 for an unrestricted procurement for Buspirone HCL Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. All bottles of 100 tablets or less must have a child resistant closure. Glass bottles are not acceptable. Solicitation # 36E79725R0024 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 04/08/2025 with a tentative closing date of April 22, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov. The estimated annual requirements are as follows: Description Size Estimated Annual Requirements (Bottles) BUSPIRONE HCL 10MG TAB 100 7,928 BUSPIRONE HCL 10MG TAB 500 179,623 BUSPIRONE HCL 15MG TAB 60 158,668 BUSPIRONE HCL 15MG TAB 500 74,023 BUSPIRONE HCL 30MG TAB 60 68,811 BUSPIRONE HCL 5MG TAB 100 4,390 BUSPIRONE HCL 5MG TAB 500 51,086 BUSPIRONE HCL 7.5MG TAB 100 42,775
Background
The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0024 for an unrestricted procurement of Buspirone HCL Tablets. This contract is aimed at supporting the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The goal is to ensure an uninterrupted source of supply for the contracted items, which will be distributed through the VA's and DOD's Pharmaceutical Prime Vendor Programs.

Work Details
The contract will include the following estimated annual requirements for Buspirone HCL Tablets:
- BUSPIRONE HCL 10MG TAB (100 count): 7,928 bottles
- BUSPIRONE HCL 10MG TAB (500 count): 179,623 bottles
- BUSPIRONE HCL 15MG TAB (60 count): 158,668 bottles
- BUSPIRONE HCL 15MG TAB (500 count): 74,023 bottles
- BUSPIRONE HCL 30MG TAB (60 count): 68,811 bottles
- BUSPIRONE HCL 5MG TAB (100 count): 4,390 bottles
- BUSPIRONE HCL 5MG TAB (500 count): 51,086 bottles
- BUSPIRONE HCL 7.5MG TAB (100 count): 42,775 bottles.

All products must have a unique NDC number and comply with packaging requirements: all bottles containing 100 tablets or less must have a child-resistant closure; glass bottles are not acceptable.

Period of Performance
The contract period will be for one year plus four pre-priced one-year option periods.

Place of Performance
The products will be delivered to various locations as specified by the VA and DOD's Pharmaceutical Prime Vendor Programs.

Overview

Response Deadline
April 23, 2025, 3:30 p.m. EDT Past Due
Posted
April 3, 2025, 3:46 p.m. EDT
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Low
Est. Value Range
Experimental
$5,000,000 - $20,000,000 (AI estimate)
Odds of Award
90%
On 4/3/25 National Acquisition Center issued Presolicitation 36E79725R0024 for Buspirone RFP due 4/23/25. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Title
Amber Zavala
Name
Amber.Zavala@va.gov   Profile
Phone
(708) 786-5245

Documents

Posted documents for Presolicitation 36E79725R0024

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Presolicitation 36E79725R0024

Award Notifications

Agency published notification of awards for Presolicitation 36E79725R0024

IDV Awards

Indefinite delivery vehicles awarded through Presolicitation 36E79725R0024

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Presolicitation 36E79725R0024

Similar Active Opportunities

Open contract opportunities similar to Presolicitation 36E79725R0024

Additional Details

Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > NAC PHARMACEUTICALS (36E797)
FPDS Organization Code
3600-36E797
Source Organization Code
500000036
Last Updated
July 31, 2025
Last Updated By
amber.zavala@va.gov
Archive Date
July 31, 2025